Abstracts from the 4th ImmunoTherapy of Cancer Conference

Autor: J. Ženka, V. Caisová, O. Uher, P. Nedbalová, K. Kvardová, K. Masáková, G. Krejčová, L. Paďouková, I. Jochmanová, K. I. Wolf, J. Chmelař, J. Kopecký, L. Loumagne, J. Mestadier, S. D’agostino, A. Rohaut, Y. Ruffin, V. Croize, O. Lemaître, S. S. Sidhu, S. Althammer, K. Steele, M. Rebelatto, T. Tan, T. Wiestler, A. Spitzmueller, R. Korn, G. Schmidt, B. Higgs, X. Li, L. Shi, X. Jin, K. Ranade, S. Koeck, A. Amann, G. Gamerith, M. Zwierzina, E. Lorenz, H. Zwierzina, J. Kern, M. Riva, T. Baert, A. Coosemans, R. Giovannoni, E. Radaelli, W. Gsell, U. Himmelreich, M. Van Ranst, F. Xing, W. Qian, C. Dong, X. Xu, S. Guo, Q. Shi, D. Quandt, B. Seliger, C. Plett, D. C. Amberger, A. Rabe, D. Deen, Z. Stankova, A. Hirn, Y. Vokac, J. Werner, D. Krämer, A. Rank, C. Schmid, H. Schmetzer, M. Guerin, J. M. Weiss, F. Regnier, G. Renault, L. Vimeux, E. Peranzoni, V. Feuillet, M. Thoreau, T. Guilbert, A. Trautmann, N. Bercovici, F. Doraneh-Gard, C. L. Boeck, C. Gunsilius, C. Kugler, J. Schmohl, D. Kraemer, B. Ismann, H. M. Schmetzer, A. Markota, C. Ochs, P. May, A. Gottschlich, J. Suárez Gosálvez, C. Karches, D. Wenk, S. Endres, S. Kobold, T. Hilmenyuk, R. Klar, F. Jaschinski, F. Augustin, C. Manzl, E. Hoflehner, P. Moser, B. Zelger, S. Köck, G. Schäfer, D. Öfner, H. Maier, S. Sopper, H. Prado-Garcia, S. Romero-Garcia, R. Sandoval-Martínez, A. Puerto-Aquino, J. Lopez-Gonzalez, U. Rumbo-Nava, A. Van Hoylandt, P. Busschaert, I. Vergote, J. Laengle, K. Pilatova, E. Budinska, B. Bencsikova, R. Sefr, R. Nenutil, V. Brychtova, L. Fedorova, B. Hanakova, L. Zdrazilova-Dubska, Chris Allen, Yuan-Chieh Ku, Warren Tom, Yongming Sun, Alex Pankov, Tim Looney, Fiona Hyland, Janice Au-Young, Ann Mongan, A. Becker, J. B. L. Tan, A. Chen, K. Lawson, E. Lindsey, J. P. Powers, M. Walters, U. Schindler, S. Young, J. C. Jaen, S. Yin, Y. Chen, I. Gullo, G. Gonçalves, M. L. Pinto, M. Athelogou, G. Almeida, R. Huss, C. Oliveira, F. Carneiro, C. Merz, J. Sykora, K. Hermann, R. Hussong, D. M. Richards, H. Fricke, O. Hill, C. Gieffers, M. P. Pinho, J. A. M. Barbuto, S. E. McArdle, G. Foulds, J. N. Vadakekolathu, T. M. A. Abdel-Fatah, C. Johnson, S. Hood, P. Moseley, R. C. Rees, S. Y. T. Chan, A. G. Pockley, S. Rutella, C. Geppert, A. Hartmann, K. Senthil Kumar, M. Gokilavani, S. Wang, M. Redondo-Müller, K. Heinonen, V. Marschall, M. Thiemann, L. Zhang, B. Mao, Y. Jin, G. Zhai, Z. Li, Z. Wang, X. An, M. Qiao, J. Zhang, J. Weber, H. Kluger, R. Halaban, M. Sznol, H. Roder, J. Roder, J. Grigorieva, S. Asmellash, K. Meyer, A. Steingrimsson, S. Blackmon, R. Sullivan, W. Sutanto, T. Guenther, F. Schuster, H. Salih, F. Babor, A. Borkhardt, Y. Kim, I. Oh, C. Park, S. Ahn, K. Na, S. Song, Y. Choi, A. Poprach, R. Lakomy, I. Selingerova, R. Demlova, S. Kozakova, D. Valik, K. Petrakova, R. Vyzula, D. Aguilar-Cazares, M. Galicia-Velasco, C. Camacho-Mendoza, L. Islas-Vazquez, R. Chavez-Dominguez, C. Gonzalez-Gonzalez, J. S. Lopez-Gonzalez, S. Yang, K. D. Moynihan, M. Noh, A. Bekdemir, F. Stellacci, D. J. Irvine, B. Volz, K. Kapp, D. Oswald, B. Wittig, M. Schmidt, R. Kleef, A. Bohdjalian, D. McKee, R. W. Moss, Mesha Saeed, Sara Zalba, Reno Debets, Timo L. M. ten Hagen, S. Javed, J. Becher, F. Koch-Nolte, F. Haag, E. M. Gordon, K. K. Sankhala, N. Stumpf, W. Tseng, S. P. Chawla, N. González Suárez, G. Bergado Báez, M. Cruz Rodríguez, A. Gutierrez Pérez, L. Chao García, D. Hernández Fernández, J. Raymond Pous, B. Sánchez Ramírez, C. Jacoberger-Foissac, H. Saliba, C. Seguin, A. Brion, B. Frisch, S. Fournel, B. Heurtault, T. Otterhaug, M. Håkerud, A. Nedberg, V. Edwards, P. Selbo, A. Høgset, T. Jaitly, J. Dörrie, N. Schaft, S. Gross, B. Schuler-Thurner, S. Gupta, L. Taher, G. Schuler, J. Vera, F. Rataj, F. Kraus, S. Grassmann, M. Chaloupka, S. Lesch, C. Heise, B. M. Loureiro Cadilha, K. Dorman

Publikováno v: Journal for ImmunoTherapy of Cancer. 5

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2946557ce1ae832710fb1dc840373e6f
https://doi.org/10.1186/s40425-017-0219-4

[Remote results of the treatment of intracapsular fractures of the femoral neck with extrarticular fixation]

Autor: K, Tukallo, F, Rataj, J, Sikorski

Publikováno v: Polski przeglad chirurgiczny. 41(12)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4459a8dc0292ea7ed267f5137ed6603a
https://pubmed.ncbi.nlm.nih.gov/5372705

PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor models.

Autor: Lesch S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Member of the German Center for Lung Research (DZL), University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Nottebrock A; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Member of the German Center for Lung Research (DZL), University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Rataj F; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Member of the German Center for Lung Research (DZL), University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Heise C; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Member of the German Center for Lung Research (DZL), University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Endres S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Member of the German Center for Lung Research (DZL), University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.; German Center for Translational Cancer Research (DKTK), partner site Munich, Munich, Germany.; Einheit Für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, Germany, Research Center for Environmental Health (HMGU), Neuherberg, Germany., Kobold S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Member of the German Center for Lung Research (DZL), University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany. Sebastian.kobold@med.uni-muenchen.de.; German Center for Translational Cancer Research (DKTK), partner site Munich, Munich, Germany. Sebastian.kobold@med.uni-muenchen.de.; Einheit Für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, Germany, Research Center for Environmental Health (HMGU), Neuherberg, Germany. Sebastian.kobold@med.uni-muenchen.de.; Division of Clinical Pharmacology, Klinikum der Universität München, Lindwurmstraße 2a, 80337, Munich, Germany. Sebastian.kobold@med.uni-muenchen.de.

Publikováno v: Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2023 Feb; Vol. 46 (1), pp. 227-235. Date of Electronic Publication: 2022 Nov 21.

T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours.

Autor: Lesch S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Blumenberg V; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.; Department of Medicine III, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Stoiber S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Gottschlich A; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Ogonek J; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Cadilha BL; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Dantes Z; Klinik und Poliklinik für Innere Medizin II, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany., Rataj F; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Dorman K; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Lutz J; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Karches CH; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Heise C; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Kurzay M; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Larimer BM; Center for Precision Imaging, Department of Radiology, Massachusetts General Hospital, Boston, MA, USA., Grassmann S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Rapp M; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Nottebrock A; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Kruger S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.; Department of Medicine III, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Tokarew N; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Metzger P; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Hoerth C; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Benmebarek MR; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Dhoqina D; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Grünmeier R; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Seifert M; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Oener A; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Umut Ö; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Joaquina S; Université de Paris, Institute Cochin, INSERM, CNRS, Paris, France.; Equipe labellisée Ligue Contre le Cancer, Toulouse, France., Vimeux L; Université de Paris, Institute Cochin, INSERM, CNRS, Paris, France.; Equipe labellisée Ligue Contre le Cancer, Toulouse, France., Tran T; Equipe labellisée Ligue Contre le Cancer, Toulouse, France.; Université de Paris, PARCC, INSERM U970, Paris, France., Hank T; Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Baba T; Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Huynh D; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Megens RTA; Institute for Cardiovascular Prevention (IPEK), University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.; Cardiovascular Research Institute Maastricht (CARIM), Department of BioMedical Engineering, Maastricht University, Maastricht, the Netherlands., Janssen KP; Department of Surgery, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany., Jastroch M; Helmholtz Diabetes Center and German Diabetes Center (DZD), Helmholtz Zentrum München, Neuherberg, Germany., Lamp D; Helmholtz Diabetes Center and German Diabetes Center (DZD), Helmholtz Zentrum München, Neuherberg, Germany., Ruehland S; LMU Biocenter, Department Biology II, Ludwig Maximilians-Universität München, Munich, Germany., Di Pilato M; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA., Pruessmann JN; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA., Thomas M; Institute of Computational Biology, Helmholtz Zentrum München (German Research Center for Environmental Health), Neuherberg, Germany.; School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany., Marr C; Institute of Computational Biology, Helmholtz Zentrum München (German Research Center for Environmental Health), Neuherberg, Germany., Ormanns S; Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany., Reischer A; Department of Medicine III, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Hristov M; Institute for Cardiovascular Prevention (IPEK), University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Tartour E; Equipe labellisée Ligue Contre le Cancer, Toulouse, France.; Université de Paris, PARCC, INSERM U970, Paris, France.; Service d'Immunologie Biologique, APHP, Hôpital Européen Georges Pompidou, Paris, France., Donnadieu E; Université de Paris, Institute Cochin, INSERM, CNRS, Paris, France.; Equipe labellisée Ligue Contre le Cancer, Toulouse, France., Rothenfusser S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany., Duewell P; Institute of Innate Immunity, University of Bonn, Bonn, Germany., König LM; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Schnurr M; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Subklewe M; Department of Medicine III, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Liss AS; Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Halama N; Department of Translational Immunotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany., Reichert M; Klinik und Poliklinik für Innere Medizin II, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany.; Center for Functional Protein Assemblies (CPA), Technische Universität München, Garching, Germany.; German Center for Translational Cancer Research (DKTK), Munich, Germany., Mempel TR; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA., Endres S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany.; German Center for Translational Cancer Research (DKTK), Munich, Germany., Kobold S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany. Sebastian.kobold@med.uni-muenchen.de.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany. Sebastian.kobold@med.uni-muenchen.de.; German Center for Translational Cancer Research (DKTK), Munich, Germany. Sebastian.kobold@med.uni-muenchen.de.

Publikováno v: Nature biomedical engineering [Nat Biomed Eng] 2021 Nov; Vol. 5 (11), pp. 1246-1260. Date of Electronic Publication: 2021 Jun 03.

Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteins.

Autor: Blaeschke F; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany., Stenger D; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany., Apfelbeck A; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany., Cadilha BL; Center for Integrated Protein Science Munich (CIPSM) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, LMU Munich, Munich, Germany., Benmebarek MR; Center for Integrated Protein Science Munich (CIPSM) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, LMU Munich, Munich, Germany., Mahdawi J; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany., Ortner E; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany., Lepenies M; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany., Habjan N; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany., Rataj F; Center for Integrated Protein Science Munich (CIPSM) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, LMU Munich, Munich, Germany., Willier S; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany., Kaeuferle T; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany.; National Center for Infection Research (DZIF), Munich, Germany., Majzner RG; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Busch DH; National Center for Infection Research (DZIF), Munich, Germany.; Institute for Medical Microbiology, Immunology and Hygiene, Technical University Munich, Munich, Germany.; Focus Group 'Clinical Cell Processing and Purification', Institute for Advanced Study, TUM, Munich, Germany., Kobold S; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Center for Integrated Protein Science Munich (CIPSM) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, LMU Munich, Munich, Germany., Feuchtinger T; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany. tobias.feuchtinger@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany. tobias.feuchtinger@med.uni-muenchen.de.; National Center for Infection Research (DZIF), Munich, Germany. tobias.feuchtinger@med.uni-muenchen.de.

Publikováno v: Blood cancer journal [Blood Cancer J] 2021 Jun 04; Vol. 11 (6), pp. 108. Date of Electronic Publication: 2021 Jun 04.